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ABSTRACT  
Aim: To provide national consensus on the range of conditions community practitioner nurse 
prescribers manage, and for which it is considered important that they can prescribe. 
Background: Around 35,000 community practitioner nurse prescribers in the UK are able to 
prescribe from a limited formulary. Although prescribing is a key role for these nurses, there has 
been a decline in the numbers of community practitioner nurse prescribers who prescribe. It is 
evident that changing patterns of client and service delivery, changes the role of community 
nurses and the conditions they manage, however, little is known about the conditions 
community practitioner nurse prescribers manage.   
Design and methods: A modified Delphi approach comprising three on-line surveys delivered to 
a national Expert Panel of eighty-nine qualified community practitioner prescribers. Data 
collection took place between January and March 2017.  
Results: Panelists reached a consensus, with consistent high levels of agreement reached, on 
nineteen conditions for which it is believed community practitioner nurse prescribers should be 
able to prescribe. Conditions identified by school nurses (n=12) and health visitors (n=7) were 
mainly acutely focused, whereas those identified by district nurses (n=9) and community staff 
nurses (n=6) included both long-term and acute conditions. 
Conclusion: Given the high degree of consensus, this list of conditions should influence any 
decisions about the items community and public health nurses should be able to prescribe. The 
findings should also influence the education and training of these nurses. 
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SUMMARY STATEMENT  
Why is this research needed? 
 Prescribing is a key role for community nurses, however, there has been a decline in the 
numbers of these nurses who prescribe from the limited range of items available to 
them in the Nurse Prescribers Formulary for Community Practitioner Nurse Prescribers  
 Although it is evident that the changing pattern of client and service delivery has 
changed the role of the community nurse, little evidence is available about the 
conditions community practitioners nurse prescribers manage  
 
 What are the key findings? 
 Overall, the modified Delphi method used in this study enabled panelists to reach a 
consensus, with consistent high levels of agreement reached, on nineteen conditions 
for which it is believed community nurse practitioner prescribers should be able to 
prescribe 
 Consensus was achieved by district nurses and community staff nurses on a number of 
chronic conditions, whereas agreement was reached on a number of more acutely 
focused conditions across all community practitioner prescriber groups 
 
How should the findings be used to influence policy/practice/research/education? 
 The conditions identified in this research provide national guidance on the items 
community practitioner nurse prescribers need to prescribe, and also international 
guidance for countries in which prescribing by community and public health nurses is 
established, and for those countries wishing to establish prescribing by these nurses. 
5 
 
 Our findings can also be used to direct national and international education and training 
for the preparation of community and public health nurses. 
 
KEYWORDS: Nurse prescribers, nurse prescribing, modified Delphi, school nurses, district 
nurses, health visitors, community staff nurses, condition management, community and public 
health nurses 
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INTRODUCTION 
Extending nurses’ scope of practice to include prescribing has been supported in a number of 
countries, including the United Kingdom (UK), the United States, New Zealand, Netherlands, 
Ireland, Australia, Canada, and Sweden (Weeks et al 2016, Kroezen et al 2011, Ball et al 2009). 
Drivers for this role include the need to address doctor shortages, improve patient access to 
medicines, make better use of nurses’ skills, and to develop advanced practitioner roles (Weeks 
et al 2016, Kroezen at al 2011). 
In the UK, changes in legislation in 1992, enabled District Nurses (DNs), and Health Visitors (HVs), 
to access prescribing training to prescribe from a limited range of items, included in the Nurse 
Prescribers’ Formulary (NPF) for Community Practitioners (Nursing and Midwifery Council 
(NMC) 2006). Items include laxatives, anti-fungal preparations, emollients, some analgesics (e.g. 
aspirin, paracetamol, ibuprofen), nicotine replacement products, anthelmintic and insecticides, 
wound dressings, catheter management preparations, stoma appliances, and wound 
management products (British Medical Association and the Royal Pharmaceutical Society 2016). 
Training (typically of 4 days duration), is now integrated into the qualifying programme for 
Specialist Community Practitioners i.e. DNs, Public Health nurses (previously known as HVs) and 
School Nurses (SNs). Community staff nurses (CSNs) without a specialist qualification in 
community nursing but with 2 years qualified experience, are also able to prescribe from the 
NPF once they have undertaken a stand-alone course of 10 days duration (NMC 2009).  
 
In 2001, independent prescribing rights were extended to include other groups of registered 
nurses, with three years qualified experience (Department of Health (DoH) 2001). These nurses 
are able to prescribe any medicine within their area of competence independently or, via 
supplementary prescribing (DoH 2005). Supplementary prescribing involves a written 
agreement, between the patient, doctor and supplementary prescriber, on a list of medicines 
from which the supplementary prescriber is able to prescribe. In contrast, independent 
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prescribers are responsible for the assessment, diagnosis, and decisions about the clinical 
management required in patients with diagnosed or undiagnosed conditions. Training for nurse 
independent supplementary prescribing is typically 6 months in length (NMC 2006). This is in 
contrast to countries such as the United States, Canada and Australia, where training to 
independently prescribe is at master’s level for registered nurses and a component of 2 year 
advanced nurse practitioner programmes (Ball et al 2009).  
 
Although there is evidence available that has explored the prescribing practices of nurse 
independent supplementary prescribers, there is very little recent evidence available that has 
explored the prescribing practices of community practitioner nurse prescribers (CPNPs). The 
evidence that is available has reported that whilst these nurses view prescribing as an important 
element of their role (Downer & Shepherd 2010, Young 2009), decreasing numbers are actively 
prescribing (Drennan 2014) with reports that items included in the NPF do not meet the needs 
of the patients these nurses manage (Hall et al 2006, Brooks et al 2004, Lewis-Evans & Jester 
2004, While & Biggs 2004). This is concerning given that prescribing has been identified as a key 
role for community nurses (Health Education England 2016, Health Education England 2015, 
NHS England 2014).  
 
BACKGROUND 
Nurse independent and supplementary prescribers, of whom there are 36,000 in the UK 
(Courtenay 2017), prescribe for a broad range of conditions (Courtenay et al 2017, Latter et al 
2010). They are safe and prescribe clinically appropriate medicines (Latter et al 2010, Latter et 
al 2005). Stakeholders are satisfied (Courtenay et al 2011, Latter et al 2011), and outcomes of 
care are comparable to medical prescribing (Weeks et al 2016, Gielen et al 2014). Between 10-
20% of CPNPs have been reported to go on to become nurse independent supplementary 
prescribers (Courtenay et al 2017a, Courtenay et al 2012, Latter et al 2010).  
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The majority of studies that have explored prescribing by CPNPs were undertaken over a decade 
ago. A review of the literature in 2004 (Latter & Courtenay 2004), designed to identify the impact 
and effectiveness of community practitioner nurse prescribing, reported that although 
prescribing by these nurses had generally been evaluated positively, there was wide variation in 
the number of items prescribed, with DNs prescribing more than HVs. A consistent theme within 
the 18 studies included in the review, was that the NPF was restrictive, with both nurses and 
patients calling for expansion to the range of medicines that nurses were able to prescribe. 
Following on from this review, low levels of prescribing amongst CPNPs have been reported 
(Drennan et al 2014, Courtenay et al 2012,Hall et al 2006). Hall et al (2006), in interviews with 
23 CPNPs and 5 prescribing leads in primary care trusts within three Strategic Health Authorities, 
identified 16% of these nurses prescribed infrequently (i.e. less than once a week) with double 
the proportion of health visitors compared with district nurses classed as infrequent prescribers. 
Furthermore, the inability by these nurses to prescribe medicines for patients they managed 
was reported to be a barrier to prescribing.  Findings from a survey of nurse, pharmacist and 
allied health professional prescribers in one Strategic Health Authority reported as many as a 
third of CPNPs did not prescribe (Courtenay et al 2012). This finding was supported in a later 
study by Drennan et al (2014) investigating nurses prescribing activities, over time, in English 
primary care settings. These researchers identified a decrease in the number of CPNPs who used 
the limited formulary, and a decrease in CPNPs who actively prescribed. 
 
There is huge diversity in community and public health nursing roles globally (World Health 
Organisation (WHO) 2017). However, typical activities of these nurses include health promotion, 
disease prevention and disease management (WHO 2017). Community and public health nurses 
have the potential to make significant contributions to the health care needs of various 
population groups in a variety of community settings and changing population profiles have 
led to international interest in the work of these nurses (WHO 2017). Evidence available 
(Nissanholtz-Gannot et al 2017, Rodden 2016, Maijala et al 2016, Kelehera & Parker 2013, Kemp 
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et al 2005), has identified a shift in focus of the care provided by these nurses. In Australia, for 
example, researchers have reported community nurses to be increasingly working in roles that 
have moved away from longer term support and care to provision of a more ‘acutely’ focussed 
episodic care (Kemp et al 2005) with increasing involvement in health promotion activities 
(Rodden et al 2016, Kelehera & Parker 2013). Similarly, in Finland and Israel, researchers have 
reported nurse’s involvement in the implementation of a variety of health educational activities 
within the primary health care context (Maijala et al 2016) and a shift in nursing tasks from 
hospitals to the community setting, a key area of involvement including health promotion 
(Nissanholtz-Gannot et al 2017).  
 
Given the increased investment in the UK in the skills of community nurses, including prescribing 
(Health Education England 2016, NHS England 2014), it is important that these nurses are able 
to prescribe medicines for the conditions they manage. The items listed in the NPF have 
remained unchanged since its inception in 1998, and it is likely, given the changing population 
profiles and changing patterns of client and service delivery, that these items no longer reflect 
the prescribing needs of these nurses. To our knowledge, there is no evidence available that has 
explored the conditions these nurses manage.  
 
THE STUDY 
Aim 
The aim of this research was to provide national consensus on the range of conditions CPNPs 
manage, and for which it is considered important that they can prescribe. 
 
Design 
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Where there is an absence of research evidence or the desire to gather opinion, structured or 
formal methods are commonly used to reach consensus. The Delphi technique is a commonly 
used formal consensus method which uses an iterative series (or rounds) of questionnaires to 
gather data and achieve group consensus (Keeney et al 2001). A benefit of the Delphi technique 
is the potential to include large numbers of participants who are geographically dispersed and 
are from diverse areas of expertise (Keeney et al 2001). The technique, unlike traditional group 
meetings, avoids the risk of meetings being dominated by one individual or influenced by 
coalitions between group members (Keeney et al 2001). A classic Delphi survey begins with a 
questionnaire containing open ended questions from which subsequent questionnaires are 
developed (Day & Boveva 2005, Hasson et al 2000). As a list of conditions for which CPNPs are 
reported to manage had already been developed from the literature, the current study used a 
modified Delphi survey, i.e. the traditional round 1 open ended questionnaire was replaced with 
this predefined list of conditions. This is an acceptable modification of the Delphi process 
(Keeney et al 2011). 
 
Participants 
The Delphi technique employs ‘experts’ as panel members as opposed to a random sample 
representative of the target population. However, there is a lack of consensus within the 
literature as to the definition of an expert (Baker et al 2006), and no consensus as to the 
optimum number of participants to be included in Delphi surveys (Keeney et al 2011). It is 
suggested that the selection of expert panel members should be dependent upon what is being 
investigated, the complexity of the problem, the homogeneity or heterogeneity of the sample 
and availability of resources (Keeney et al 2011). Although there is no consensus within the 
literature as to what is defined as large or small, larger panels are recommended for 
heterogenous groups and smaller panels for homogenous groups (Skulmonski et al 2007). Larger 
samples are reported to increase the complexity and difficulty of collecting data, reaching 
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consensus, conducting analysis, and verifying results (Skulmonski et al 2007), and it is 
recommended that researchers be explicit about criteria used to include participants in a study 
(Trevelyan & Robinson 2015). Given the topic being investigated, and resource constraints, the 
decision was made to include a relatively homogenous sample (i.e. recruiting only CPNPs) and 
‘Expert’ for the current Delphi study was defined as Specialist Community Practitioners with a 
prescribing qualification and CSNs (without a specialist qualification) qualified to prescribe.  
Participants of the expert panel were recruited through a purposive sampling method to create 
a database reflecting the range of community nurses able to prescribe medicines from the NPF 
for community practitioners. In order to ensure that the full range of these nurses was included 
on the panel, and that they were representative of CPNPs across the UK, contact was made by 
MC with Chief Executive Officers, Directors, Chairs, and Professional Leads of national bodies 
representing UK community practitioner groups. These organisations included the Community 
Practitioner and Health Visitors’ Association, the Royal College of Nursing (RCN), the Institute of 
Health Visitors’, the Queens Nurse Institute, and the Association for Prescribers. These 
individuals were informed about the project and provided with details about the research. They 
were also invited to share these details with their members. Specialist Community Practitioners 
with a prescribing qualification and CSN prescribers (without a specialist qualification) were 
invited to contact the researchers, if they were keen to become an expert member of the Delphi 
panel. The current survey aimed to include all professionals who expressed an interest to take 
part and who fulfilled our definition of ‘expert’.  
One hundred and fifty community nurses contacted the researchers and expressed an interest 
to participate. Each was sent a participant information sheet by email and provided with the 
opportunity to address any queries they may have had with a researcher. The participant 
information sheet highlighted that questionnaire data would be anonymous, that all information 
collected during the course of the study would be kept strictly confidential, and that completion 
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of questionnaires provided implied consent to participate. Of the 150 community nurses who 
expressed an interest to take part, 89 community nurses agreed to participate.  
Data collection and analysis 
The survey was conducted across three rounds. Bristol Online Survey —a tool for creating web 
surveys—was used to develop each round of the on-line questionnaire survey. A link to each 
survey was distributed via email to all participants who had confirmed their participation, 
followed by two follow-up reminder emails, at one week intervals per survey round. Data 
collection took place between January and March 2017.  
Round 1 Elicitation of the conditions managed by community practitioner prescribers 
A list of 15 conditions for which CPNPs are reported to manage, was developed from the 
literature (See Table 1). 
 
Delphi panel members were asked to identify from this list, the conditions they manage, 
prescribe for, treat, or provide advice. Space was also provided for panel members to list any 
additional conditions not included on the list. Demographic details collected included role, if 
they were a qualified Nurse Independent Supplementary Prescriber, job band, employer, years 
qualified as a prescriber, age range, setting in which participant worked, service provided, 
whether participants prescribed, and the number of items prescribed per month, was also 
collected. 
  
Refining factors and actions 
Questionnaire data were analysed within SPSS version 17 and descriptive statistics calculated 
for each question. A list of conditions representing those that expert panel member reported 
that they managed, prescribe for, treat, or provide advice for, was then developed.  
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Round 2 – Building consensus on priorities 
An email was sent to members of the expert panel inviting them to participate in round 2 of the 
Delphi process. In this round, participants were asked to use a 5 point Likert scale (1=strongly 
agree to 5 =strongly disagree) to rate each condition identified in round 1, with regards to the 
extent to which they felt it was important that they could prescribe for it. Median scores and 
interquartile ranges (IQRs) were calculated for responses to each condition, for each community 
nurse group (i.e. DNs, HVs, SNs, and CSNs), in order to characterise the answer category above 
and below which 50% of the answers fell. IQRs which form the distance between the 25th and 
75th percentiles were used to represent the spread of the data and to assess the level of 
consensus per question. Although there is no agreement on the best method used to determine 
consensus, median score and IQR is a frequently used method (Skulmoski et al 2007) and is 
considered robust (Stark et al 2015). Responses where the median was less than or equal to 2 
(i.e. a high level of agreement that participants viewed it as important to their role that they can 
prescribe for this condition) with a small IQR (less than or equal to 1.5), were considered 
important conditions that have reached consensus across each community practitioner group 
and taken forward to the 3rd round. 
 
Round 3 – Reaching consensus on priorities  
In the final round, participants were asked to rank each condition with regards to how much of 
a priority it was that they were able to prescribe for it. Responses were inversely scored and 
collated. Priorities were defined as the conditions receiving the highest total scores for each 
group.  
Ethical consideration 
Ethical approval for the study was provided by the School of Healthcare Sciences Research 
Governance and Ethics Committee, Cardiff University (427c).  
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RESULTS  
A total of 89 CPNPs agreed to become members of the expert panel, of whom 80 (90%) 
completed round 1 questionnaire, 70/80 (88%) completed round 2, and 65/70 (92%) responded 
to round 3. Table 2 provides a description of the different types of CPNP who responded to each 
round (See Figure 1 for a summary of the Delphi process). 
 
Round 1 
Eighty (90%) participants responded to the initial survey. Most of these participants were HVs. 
Only small numbers were SNs (see Table 2). Forty-one (51.3%) participants had more than 5 
years’ experience as a qualified prescriber and 67 (83.8%) participants reported that they 
prescribed. The demographic characteristics of these participants are described in Table 3. 
A list of 30 conditions were identified by respondents as those for which they managed, 
prescribe for, treat, or provide advice (see Table 4).  
 
Round 2 
Seventy (88%) participants responded to the second round. See Table 5 for a description of the 
median scores and IQRs for each of the 30 conditions per CPNP group  
 
Responses from DNs identified 9 conditions, for which there was a high level of agreement, that 
it was important to their role that they could prescribe medicines. HVs showed a high level of 
agreement across 7 conditions. SNs agreed on 12 conditions, and CSNs 6 conditions. These 
conditions were taken forward into round 3.   
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Round 3 
Sixty five (92%) participants responded to the third round. Conditions, ranked in priority order 
(for each group), are presented in Table 6.  
DISCUSSION 
The aim of this study was to provide national consensus on the range of conditions CPNPs 
manage, and for which it is considered important that they can prescribe. Starting with a 
predetermined list of conditions developed from the literature, the traditional round 1 of the 
Delphi survey i.e. item generation was unnecessary. Overall, the modified Delphi method used 
in this study enabled panelists to reach a consensus, with consistent high levels of agreement 
reached, on nineteen conditions. This included 5 additional conditions (skin infections, 
lymphedema, post immunization fever, infant colic, and nocturnal enuresis) contributing to 
round 2. Confidence in reaching consensus means that we now have a comprehensive list of 
conditions for which each group of CPNPs believe it is important for them to be able to prescribe.  
In line with previous research (Herklotts et al 2015, Daughtry and Hayter, 2010; Downer and 
Shepherd, 2010, Young 2009, While & Biggs 2004) CPNPs in our study valued prescribing as an 
important element of their role. Consensus was achieved by DNs and CSNs on a number of 
chronic conditions, whereas agreement was reached on a number of more acutely focused 
conditions across all CPNP groups.  
 
Conditions identified by HVs (such as infestation, fungal infections, dry skin) supports the results 
of previous research (Ellefson 2001) that HVs have a significant role in health promotion and 
early intervention and aligns with the role HVs play in supporting parents and carers to recognise 
and act upon childhood illnesses (NHS England 2014). Contraception and sexual health and 
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smoking cessation, rated as priority areas by SNs, concurs with themes identified in research by 
UK researchers Hoekstra et al (2016). This also corresponds to national guidance in which a key 
role of these nurses is to reduce under 18 conceptions, reduce smoking prevalence, and 
chlamydia diagnosis (Public Health England 2014). Although DNs and CSNs primarily identified 
chronic conditions as those for which they believed they needed to prescribe, a number of acute 
conditions were also identified. This aligns with the complex care needs of the patients these 
nurses have been reported to manage in the UK (Queens Nurse Institute 2014). Our findings also 
align with the international research that has explored community and public health nursing 
roles in countries including Australia (Rodden 2016, Kelehera & Parker 2013, Kemp et al 2005), 
Finland (Maijala et al 2016), the US (Shaeffer et al 2016), and Israel (Nissanholtz-Gannot et al 
2017 ), the findings of which report the increasing involvement of these nurses in acute episodic 
care and health promotion activities.   
 
Although participants in our study believed it was important that they were able to prescribe, 
they typically only prescribed a small number of items a month which supports earlier evidence 
(Hall et al 2006, While & Biggs 2004). This may suggest that prescribing knowledge is applied in 
other ways than physically writing a prescription which aligns with previous research (Courtenay 
et al 2017a, Herklotts et al 2015, Courtenay et al 2012), nurses reporting that they use their 
prescribing knowledge to undertake a range of other activities such as making recommendations 
to another healthcare professional to prescribe a medicine or, making recommendations to a 
patient to buy a medication over the counter, and medicines reviews. 
Given the increased investment in the skills of community and public health nurses globally, our 
findings should be of international interest. Strategies are required to address health service 
demands in low-, middle- and high-income countries, extending nurses scope of practice to 
include prescribing is one such strategy. Strengthening nurses’ capacity in this way improves 
their ability to reach more people with quality health services (Weeks et al 2016). Although it is 
recognised that the findings of this work originate from a UK perspective, and so leaves open 
17 
 
the need for adaptation to other healthcare systems and consideration of other national and 
regional concerns, our findings provide some guidance for those countries in which prescribing 
by community and public health nurses is established, and for those countries wishing to 
establish prescribing by these nurses, with regards to the conditions these nurses manage and 
so the medicines they will need to prescribe. Our findings can also be used to direct national 
education and training for the preparation of community and public health nurses. If proposals 
(NMC 2017), enabling community nurses to access training to prescribe immediately upon 
qualifying as a 1st level registered nurse are accepted, it will also be important to include some 
of this preparation in undergraduate nurse education programmes.    
 
Findings from this study could be used to inform further survey work, involving a larger sample 
of CPNPs, or, patients and other members of the community healthcare team. This would help 
to validate study findings, and so may have a greater influence on policy. Another important 
next step would be to investigate how prescribers decide whether to expand their prescribing 
competencies to new areas of practice, perhaps moving on to undertake nurse independent and 
supplementary prescribing training. Less than 10% of the CPNPs in our study were qualified as 
nurse independent and supplementary prescribers and this is fewer than the figures of between 
10-20% reported previously (Courtenay et al 2017a, Courtenay et al 2012, Latter et al 2010). If 
training interventions, designed to help these prescribers feel confident to identify areas of 
practice in which they would like to expand their prescribing competencies, could be identified, 
this has the potential to lead to improved patient experience and cost savings for the NHS.  
LIMITATIONS  
The main strength of our work is that it is based on responses from a national panel of defined 
experts, had a good response rate, and provides information on the range of conditions that 
CPNPs manage, and for which it is considered important that they can prescribe. However, some 
limitations also need to be recognised. First, although expert panel members who responded to 
each Delphi round, included each of the different groups of CPNPs, only small numbers were 
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SNs. Therefore, our findings may not present an accurate picture of this population rather, they 
may represent the views of DNs, HV and CSN prescribers. Second, we could have included other 
groups on the expert panel e.g. doctors and patients. We acknowledge that for care to be patient 
centred, patients need to participate in the research that informs healthcare decisions, however, 
given resource constraints and the, problems associated with large heterogenous samples (i.e. 
difficulties surrounding data collection/analysis, reaching consensus, and verifying results) 
(Skulmonski 2007), the decision was made to include only CPNP on the expert panel. As such, 
our findings may not be representative of the wider population.  
Third, only those conditions that met consensus in round 2, were taken forward to round 3. 
Therefore, although participants were aware of the conditions upon which consensus had been 
reached, they were not provided with the opportunity to reflect on their initial judgement. 
Fourth, it is important to recognise that the results of Delphi studies are ‘group consensus’ and 
not necessarily ‘best’, ‘expert’ or ‘correct’ results (Trevelyan & Robinson 2015).)   
CONCLUSION 
Given the high degree of consensus, this list of conditions should influence any decisions about 
the items community and public health nurses should be able to prescribe. The findings should 
also influence the education and training of these nurses. 
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Table 1 – A list of conditions for which community nurse practitioner nurse prescribers are 
reported to manage 
 
Asthma 
Catheter management 
Conjunctivitis 
Constipation 
Contraception and sexual health 
Dry skin 
Fungal infections (skin and oral) 
Infestations (threadworm, lice, scabies) 
Mastitis 
Nappy rash 
Pain 
Smoking cessation 
Stoma management 
Varicose veins, varicose eczema, and leg ulcers 
Wounds 
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Table 2 – Community practitioners nurse prescribers’ who responded to each round 
 
Community Practitioner Nurse Prescriber 
 
Round 1 
n=80 
Round 2 
n=70 
 
Round 3 
n=65 
 n % n % n % 
Health Visitor 38  47.5 30 42.8 30 46.1 
District Nurse 21  26.25 21 30.0 18 27.7 
School Nurse 7  8.75 7 10.0 5 7.7 
Community staff nurse 14  17.5 12 17.1 12 18.4 
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Table 3 – Demographic details of those responding to round 1 
  
Demographic Information Round 
1(n=80 or 
90%  
 n % 
Role   
Health Visitor 38  47.5 
District Nurse 21  26.25 
School Nurse 7  8.75 
Community staff nurses 14  17.5 
Job band (i.e. Registered Nurses in the UK are put into a 
Band. Band 5 = lower Band. Band 8 or 9 = higher Band. A 
higher Band reflects salary/managerial responsibility/clinical 
expertise) 
 
  
5 4 5.0 
6 37 46.3 
7 30 37.6 
8A 7 8.8 
8C 1 1.3 
Prescribing qualification   
Nurse Independent Supplementary Prescriber 7 8.8 
Employer   
National Health Service Trust 55 68.8 
Community Trust 7 8.8 
Independent Sector providing services on behalf of the NHS 13 16.3 
Other 4 5.0 
Age range   
25 or under 2 2.5 
26-35 6 7.5 
36-45 23 28.8 
46-55 years 38 47.5 
56 or over 10 12.5 
Years qualified as a prescriber   
Less than 1 year 4 5.0 
1-3 years 23 28.8 
4-5 years 10 12.5 
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More than 5 years 41 51.3 
Setting   
Primary care 28 35.0 
Community 56 70.0 
Service provided   
National Health Service Trust Hospital out-patient 1 1.3 
National Health Service Trust Community clinic 29 36.3 
General practice service 6 7.5 
Her Majesty’s Prison Services 1 1.3 
Community/intermediate care 60 75.0 
Out of hours 2 2.5 
Armed forces 1 1.3 
Other 5 6.3 
Do you prescribe   
Yes 67 83.8 
No 8 10.0 
Number of items prescribed in a typical month   
1-5 33 41.3 
6-10 15 18.8 
11-20 7 8.8 
21-30 4 5.0 
31-40 3 3.8 
41-50 0 0 
Over 50 9 11.3 
Due to missing data from participants who chose not to disclose demographic information, the 
percentages do not always equal 100%. Some respondents worked across both primary and secondary 
care settings, and provided more than one service, therefore, these percentages do not equal 100% 
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Table 4 - List of Conditions identified in round 1 Delphi  
Conditions identified from the original list that 
panel members manage, prescribe for, treat, or 
provide advice.  
 
Asthma 
Catheter management 
Conjunctivitis 
Constipation 
Contraception and sexual health 
Dry skin 
Fungal infections (skin and oral) 
Infestations (threadworm, lice, scabies) 
Mastitis 
Nappy rash 
Pain 
Smoking cessation 
Stoma management 
Varicose veins, varicose eczema, and leg ulcers 
Wounds 
 
Additional conditions not included on the list 
 
Burns 
Chest infections 
Chronic Oedema 
Chronic obstructive pulmonary disease 
Depression 
Earwax 
Heart failure 
Infant colic 
Lymphedema 
Nocturnal enuresis 
Osteoporosis 
Post immunisation fever 
Psoriasis 
Skin infections 
Urinary tract infections 
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Table 5 - Median scores and interquartile ranges for each of the 30 conditions per community 
practitioner nurse prescriber group 
 
Condition District Nurses 
 
Health Visitors 
 
School Nurses 
 
Community staff 
nurses 
 
 Median IQR Median IQR Median IQR Median IQR 
Asthma 4.0 2.0 4.0 2.0 1.0 4.0 3.0 3.25 
Catheter 
management 
1.0 0.0 5.0 0.0 4.0 2.0 3.0 4.0 
Conjunctivitis 3.0 3.0 2.0 3.0 1.5 1.0 1.0 3.0 
Constipation 1.0 0.0 2.0 1.75 1.0 1.0 1.0 0.0 
Contraception 
and sexual 
health 
5.0 2.0 2.5 3.0 1.0 0.0 5.0 0.5 
Dry skin 1.0 0.0 1.0 0.0 1.0 0.0 1.0 0.0 
Fungal 
infections 
(skin and oral) 
1.5 1.0 1.0 0.0 1.0 1.0 1.0 1.0 
Infestations 
(threadworm, 
lice, scabies) 
3.0 3.0 1.0 1.0 1.0 1,0 2.0 2.0 
Mastitis 5.0 2.0 1.0 1.5 2.5 1.5 4.0 4.0 
Nappy rash 3.0 2.75 1.0 0.0 2.0 2.0 1.0 4.0 
Pain 2.5 0.75 2.0 2.25 1.5 1.0 1.0 1.0 
Smoking 
cessation 
2.0 3.0 2.0 2.5 1.0 1.0 5.0 0.5 
Stoma 
management 
1.0 1.0 5.0 0.0 4.0 2.0 3.0 4.0 
Varicose 
veins, varicose 
eczema, and 
leg ulcer  
1.0 0.0 5.0 4.0 3.0 3.0 1.0 1.75 
Wounds 1.0 0.0 5.0 1.25 3.5 1.25 1.0 0.0 
Burns 2.0 1.75 5.0 1.25 4.0 2.0 1.5 2.0 
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Chest 
infections 
3.0 1.0 5.0 1.5 4.0 2.0 2.0 1.75 
Chronic 
oedema 
2.0 2.0 5.0 0.0 4.0 2.0 1.5 4.0 
Chronic 
obstructive 
pulmonary 
disease 
4.0 2.0 5.0 1.0 4.0 2.0 5.0 0.5 
Depression 4.0 1.0 4.0 2.0 3.5 3.25 5.0 2.25 
Earwax 1.0 1.75 4.0 2.0 2.5 3.25 3.0 4.0 
Heart failure 4.0 1.75 5.0 0.0 4.0 2.0 5.0 0.5 
Infant colic 5.0 2.0 1.0 1.0 1.5 1.0 2.5 4.0 
Lymphedema 1.0 1.0 5.0 0.0 4.0 2.0 1.5 1.75 
Nocturnal 
enuresis 
3.0 2.0 4.0 2.0 1.0 1.0 4.5 2.25 
Osteoporosis 4.0 2.0 5.0 1.0 4.0 2.0 4.5 1.25 
Post 
immunisation 
fever 
5.0 3.0 1.0 1.0 1.5 1.0 2.0 2.5 
Psoriasis 2.0 2.0 5.0 1.5 3.0 2.0 4.0 4.0 
Skin infections 
(such as 
infected 
eczema or 
impetigo) 
1.5 1.0 2.0 2.0 2.0 1.0 1.0 1.0 
Urinary tract 
infections 
2.0 1.75 5.0 2.0 3.0 4.0 2.0 2.5 
*Shaded areas signify the conditions for which there was high level of agreement amongst the different 
CPNP groups, that it was important to their role that they could prescribe medicines  
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Table 6 – Conditions ranked in order of priority per community practitioner nurse prescriber 
group 
 
Rank District Nurses Health Visitors School Nurses Community 
staff nurses 
1 Wounds Fungal 
infections (skin 
and oral) 
Contraception 
and sexual 
health 
Wounds 
2 Varicose veins, 
varicose 
eczema, and leg 
ulcers  
Dry skin Smoking 
cessation  
Skin infections 
3 Catheter care  Nappy rash  Dry skin  Constipation 
4 Constipation Mastitis  Infestations 
(threadworm, 
lice, scabies) 
Pain 
5 Dry skin  Infant colic Constipation  Fungal 
infections (skin 
and oral) 
6 Skin infections Infestations 
(threadworm, 
lice, scabies) 
Nocturnal 
enuresis 
Dry skin  
7 Fungal 
infections (skin 
and oral) 
Post 
immunisation 
fever 
Skin infections   
8 Stoma care   Fungal 
infections (skin 
and oral) 
1 
9 Lymphedema   Pain  
10   Post 
immunisation 
fever 
 
11   Conjunctivitis   
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Figure 1 – Summary of the Delphi process 
 
 
 
 
 
 
 1st Round 
Identify from the list of 
conditions those you manage, 
prescriber for, treat, or provide 
advice. List any additional 
conditions not in the list 
Expert Panel 
89 community 
practitioner 
nurse 
prescribers  
89 community 
pracr 
Analysis of 1st round 
List of conditions representing 
those that Expert panel 
members manage, prescribe for, 
treat, or provide advice, 
developed.    
2nd Round 
Panel asked to rate each condition 
on a 5-point Likert scale with regards 
to the extent to which they viewed it 
as important that they could 
prescribe for it 
 
Analysis of 2nd round 
Criteria for inclusion in round 
3 applied. Preparation of 3rd 
round questionnaire 
3rd Round 
Panel asked to rank each 
condition with regards to how 
much of a priority it was that 
they could prescribe for it  
3rd round analysis  
FINAL RESULTS 
CONSENSUS ON HIGHEST RANKED CONDITIONS  
